학술논문

Vital Sign Monitoring for Cancer Patients Based on Dual-Path Sensor and Divided-Frequency-CNN Model
Document Type
Periodical
Source
IEEE Journal of Biomedical and Health Informatics IEEE J. Biomed. Health Inform. Biomedical and Health Informatics, IEEE Journal of. 28(5):2636-2649 May, 2024
Subject
Bioengineering
Communication, Networking and Broadcast Technologies
Components, Circuits, Devices and Systems
Computing and Processing
Signal Processing and Analysis
Optical fiber sensors
Heart rate
Time series analysis
Pain
Monitoring
Optical fibers
Optical fiber filters
Dual-path micro-bend optical fiber sensor
vital signs
stable phase extraction
frequency division
DFC
Language
ISSN
2168-2194
2168-2208
Abstract
Monitoring vital signs is a key part of standard medical care for cancer patients. However, the traditional methods have instability especially when big fluctuations of signals happen, while the deep-learning-based methods lack pertinence to the sensors. A dual-path micro-bend optical fiber sensor and a targeted model based on the Divided-Frequency-CNN (DFC) are developed in this paper to measure the heart rate (HR) and respiratory rate (RR). For each path, features of frequency division based on the mechanism of signal periodicity cooperate with the operation of stable phase extraction to reduce the interference of body movements for monitoring. Then, the DFC model is designed to learn the inner information from the features robustly. Lastly, a weighted strategy is used to estimate the HR and RR via dual paths to increase the anti-interference for errors from one source. The experiments were carried out on the actual clinical data of cancer patients by a hospital. The results show that the proposed method has good performance in error (3.51 (4.51$\%$) and 2.53 (3.28$\%$) beats per minute (bpm) for cancer patients with pain and without pain respectively), relevance, and consistency with the values from hospital equipment. Besides, the proposed method significantly improved the ability in the report time interval (30 to 9 min), and mean / confidential interval (3.60/[−22.61,29.81] to −0.64 / [−9.21,7.92] for patients with pain and 1.87 / [−5.49,9.23] to −0.16 / [−6.21,5.89] for patients without pain) compared with our previous work.